“Words are powerful”
Regulatory definitions are important in the context of real-world evidence (RWE) studies and real-world research for several reasons:
[1] Consistency: Regulatory definitions provide a consistent framework for generating and evaluating RWE across different stakeholders, including regulatory agencies, industry, and academia. By providing a clear and consistent definition of RWE, stakeholders can ensure that they are using the same language and criteria for evaluating the quality and relevance of RWE.
[2] Standards: Regulatory definitions help establish standards for the use of RWE in regulatory decision-making. For example, regulatory definitions may specify the types of RWE that are acceptable for use in regulatory submissions, the study designs that are appropriate for generating RWE, and the quality standards that must be met to ensure the reliability and validity of RWE.
[3] Decision-making: Regulatory definitions facilitate regulatory decision-making by providing a clear framework for evaluating the quality and relevance of RWE. By establishing clear criteria for evaluating RWE, regulatory agencies can make more informed decisions about the safety, efficacy, and quality of healthcare products.
[4] Transparency: Regulatory definitions promote transparency by providing a clear and consistent framework for generating and evaluating RWE. This can help ensure that stakeholders are aware of the criteria used to evaluate RWE and can provide input into the development of regulatory definitions.
[5] Compliance: Regulatory definitions help ensure compliance with regulatory requirements. By providing a clear definition of RWE and the standards for generating and evaluating it, stakeholders can ensure that their studies and research meet regulatory requirements.
In summary, regulatory definitions are important in the context of RWE studies and real-world research because they provide consistency, establish standards, facilitate decision-making, promote transparency, and ensure compliance with regulatory requirements. By providing a clear and consistent framework for generating and evaluating RWE, regulatory definitions can help stakeholders make more informed decisions about the safety, efficacy, and quality of healthcare products.
Share this story...
Real World Evidence (RWE) 101 – Is ICH GCP Applicable to Non-Interventional Studies?
RWE 101 - Is ICH GCP Applicable to Non-Interventional Studies? No, the International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guidelines are not applicable to non-interventional studies [...]
Real World Evidence (RWE) 101 – Ethical Principles and Safeguards for Medical AI in the Context of Real World Evidence
RWE 101 - Real World Evidence (RWE) 101 - Ethical Principles and Safeguards for Medical AI in the Context of Real World Evidence Medical AI applications hold [...]
Real World Evidence (RWE) 101 – The Declaration of Helsinki
RWE 101 - The Declaration of Helsinki The Declaration of Helsinki is a set of ethical principles that govern the conduct of medical research involving human subjects. [...]
Real World Evidence (RWE) 101 – Ethical Foundation of RWE Research
RWE 101 - Real World Evidence (RWE) 101 - Ethical Foundation of RWE Research Real-world evidence (RWE) research, which is the study of data from real-world settings, is [...]
Real World Evidence (RWE) 101 – The Impact of GDPR on RWE Research
RWE 101 - Real World Evidence (RWE) 101 - The Impact of GDPR on RWE Research The General Data Protection Regulation (GDPR) is a regulation in EU [...]
Real World Evidence (RWE) 101 – De-Identification versus Pseudo-Anonymisation
RWE 101 - Real World Evidence (RWE) 101 - De-Identification versus Pseudo-Anonymisation De-identification and pseudo-anonymization are two commonly used techniques for protecting personal information in real world [...]







